Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Sufentanil and Postoperative Delirium in Gastric Cancer Surgery
NCT05596071Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jun 2016
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of sufentanil in postoperative delirium (POD), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Incidence of postoperative delirium. Started Jun 2016; status: completed.
02
Drugs
sufentanil
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05596071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05596071.